Yi Xu

ORCID: 0009-0007-4102-8797 · 4 papers in corpus · active 2010-2022

Study types

  • article 2

Condition tags

  • endometriosis 2
  • die_deep_infiltrating 1
article 2022
Safety, pharmacokinetics, and pharmacodynamics of SHR7280, an oral gonadotropin-releasing hormone antagonist in healthy premenopausal women
Frontiers in pharmacology ·doi:10.3389/fphar.2022.1027648

Background: Treatment with gonadotropin-releasing hormone (GnRH) antagonists is a powerful strategy to suppress gonadotropin activity in women with sex hormone-dependent disorders. Herein, we provide the safety, pharmacokinetics (PK), and p…

2021
ETV6-NTRK3 is Associated With Trisomy 8 and Sensitive to TRK Inhibitor in Hematologic Malignancy: Case Report of a Refractory AML and Review of the Literature
·doi:10.21203/rs.3.rs-143398/v1
2020
MicroRNA-195 Prevents Hippocampal Microglial Polarization Towards The M1 Phenotype Induced By Chronic Brain Hypoperfusion Through Regulating CX3CL1/CX3CR1 Signalling
·doi:10.21203/rs.3.rs-25459/v1
article 2010
Expression and significance of serum MMP-9 in patients with endometriosis

Objective:To detect the level of serum matrix metalloproteinases-9 (MMP-9) in patients with endometriosis,explore the effect and significance of MMP-9 in endometriosis.Methods:Serum samples of 35 patients with endometriosis were collected,i…